Dual targeting of tumoral cells and immune microenvironment by blocking the IL-33/IL1RL1 pathway
Abstract Leukemia stem cells (LSCs) are a small yet powerful subset of leukemic cells that possess the ability to self-renew and have a long-term tumorigenic capacity, playing a crucial role in both leukemia development and therapy resistance. These LSCs are influenced by external and internal facto...
Saved in:
| Main Authors: | Denggang Fu, Hua Jiang, Alan Long, Ella Harris, Hongfen Guo, Maegan L. Capitano, John Wrangle, Joshua R. Faust, Anilkumar Gopalakrishnapillai, Santhosh Kumar Pasupuleti, Baskar Ramdas, Reuben Kapur, Sonali P. Barwe, Nai-Kong V. Cheung, Sophie Paczesny |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-61567-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ST2/IL-33 axis blockade inhibits regulatory T cell cytotoxicity towards CD8 T cells in the leukemic niche
by: Hua Jiang, et al.
Published: (2025-07-01) -
The Influence of Genetic Polymorphisms of IL33 and IL1RL1 Genes on the Immunopathogenesis of Periodontitis
by: Aléia Harumi Uchibaba Yamanaka, et al.
Published: (2025-01-01) -
IL1RL1 variant may affect the response to type 2 biologics in patients with severe asthma
by: Kenta Nishi, et al.
Published: (2025-01-01) -
Recurrence of acute allergic asthma depends on the role of ILC2 driven by Il1rl1 signaling
by: Hui Gan, et al.
Published: (2025-05-01) -
IL-15: from discovery to FDA approval
by: Zihai Li, et al.
Published: (2025-02-01)